1. Home
  2. JAZZ
  3. JAZZ News

Latest Jazz Pharmaceuticals plc (Ireland) (JAZZ) News on November 15, 2024

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock?
JAZZ

Zacks

a day ago

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock?

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest
JAZZ

Simply Wall St.

a day ago

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest

JAZZ

MT Newswires

2 days ago

Jazz Pharmaceuticals Insider Sold Shares Worth $456,617, According to a Recent SEC Filing

Jazz (JAZZ) Upgraded to Buy: Here's Why
JAZZ

Zacks

2 days ago

Jazz (JAZZ) Upgraded to Buy: Here's Why

JAZZ or CTLT: Which Is the Better Value Stock Right Now?
JAZZ

Zacks

2 days ago

JAZZ or CTLT: Which Is the Better Value Stock Right Now?

Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
JAZZ

Zacks

2 days ago

Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High?

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?
JAZZ

Zacks

2 days ago

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

JAZZ

Argus Research

3 days ago

JAZZ: Raising target price to $134.00

Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
JAZZ

Simply Wall St.

4 days ago

Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

JAZZ

Morningstar Research

4 days ago

Analyst Report: Jazz Pharmaceuticals plc

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know
JAZZ

Zacks

4 days ago

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know

Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
JAZZ

BioPharma Dive

7 days ago

Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value

JAZZ

Morningstar Research

8 days ago

Analyst Report: Jazz Pharmaceuticals plc

Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
JAZZ

GuruFocus.com

8 days ago

Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key Metrics
JAZZ

Zacks

9 days ago

Compared to Estimates, Jazz (JAZZ) Q3 Earnings: A Look at Key Metrics

Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Top Estimates
JAZZ

Zacks

9 days ago

Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Top Estimates

JAZZ

Associated Press Finance

9 days ago

Jazz: Q3 Earnings Snapshot

Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results
JAZZ

PR Newswire

9 days ago

Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results

JAZZ

Argus Research

10 days ago

JAZZ: Rating decreased to a HOLD

Insights Into Jazz (JAZZ) Q3: Wall Street Projections for Key Metrics
JAZZ

Zacks

11 days ago

Insights Into Jazz (JAZZ) Q3: Wall Street Projections for Key Metrics

Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia
JAZZ

PR Newswire

15 days ago

Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia

Esperion Therapeutics (ESPR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
JAZZ

Zacks

15 days ago

Esperion Therapeutics (ESPR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
JAZZ

Zacks

16 days ago

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?

With A 10% Return On Equity, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A Quality Stock?
JAZZ

Simply Wall St.

17 days ago

With A 10% Return On Equity, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A Quality Stock?

Jazz Pharmaceuticals plc (JAZZ): Among the Best Stocks to Buy for High Returns in 2024
JAZZ

Insider Monkey

20 days ago

Jazz Pharmaceuticals plc (JAZZ): Among the Best Stocks to Buy for High Returns in 2024

Jazz Pharmaceuticals price target raised to $179 from $175 at RBC Capital
JAZZ

TipRanks

22 days ago

Jazz Pharmaceuticals price target raised to $179 from $175 at RBC Capital

Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024
JAZZ

PR Newswire

23 days ago

Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024

JAZZ

MT Newswires

23 days ago

RBC Raises Price Target on Jazz Pharmaceuticals to $179 From $175, Keeps Outperform Rating

Avadel wins FDA approval for narcolepsy drug Lumryz in children
JAZZ

Pharmaceutical Technology

a month ago

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker
JAZZ

Motley Fool

a month ago

Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker

Wall Street Analysts Think Jazz (JAZZ) Could Surge 51.8%: Read This Before Placing a Bet
JAZZ

Zacks

a month ago

Wall Street Analysts Think Jazz (JAZZ) Could Surge 51.8%: Read This Before Placing a Bet

Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now?
JAZZ

Zacks

a month ago

Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now?

Is Jazz Pharmaceuticals plc (JAZZ) the Most Promising Biotech Stock According to Hedge Funds?
JAZZ

Insider Monkey

a month ago

Is Jazz Pharmaceuticals plc (JAZZ) the Most Promising Biotech Stock According to Hedge Funds?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?
JAZZ

Zacks

a month ago

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ Stock Soars After Combo Therapy Meets Goal in Lung Cancer Study
JAZZ

Zacks

a month ago

JAZZ Stock Soars After Combo Therapy Meets Goal in Lung Cancer Study

Is Jazz Pharmaceuticals (JAZZ) the Best Small-Cap Value Stock to Buy According to Hedge Funds?
JAZZ

Insider Monkey

a month ago

Is Jazz Pharmaceuticals (JAZZ) the Best Small-Cap Value Stock to Buy According to Hedge Funds?

Jazz Pharmaceuticals’ Zepzelca combination meets endpoints in lung cancer trial
JAZZ

TipRanks

a month ago

Jazz Pharmaceuticals’ Zepzelca combination meets endpoints in lung cancer trial

Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
JAZZ

Benzinga

a month ago

Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer

PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
JAZZ

PR Newswire

a month ago

PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

JAZZ

MT Newswires

a month ago

Jazz Pharmaceuticals Reports Positive Preliminary Results in Clinical Trial of Potential Lung Cancer Treatment

Jazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
JAZZ

PR Newswire

a month ago

Jazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data
JAZZ

BioPharma Dive

a month ago

Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data

Wall Street Analysts Favor Jazz Pharmaceuticals plc (JAZZ) for Biopharma Growth
JAZZ

Insider Monkey

a month ago

Wall Street Analysts Favor Jazz Pharmaceuticals plc (JAZZ) for Biopharma Growth

Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler?
JAZZ

Insider Monkey

a month ago

Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Will Auvelity & Sunosi Fuel Axsome's Growth Amid Stiff Competition?
JAZZ

Zacks

a month ago

Will Auvelity & Sunosi Fuel Axsome's Growth Amid Stiff Competition?

Jazz Pharmaceuticals plc (JAZZ): Among The Stocks With Biggest Upside Potential According to Hedge Funds
JAZZ

Insider Monkey

a month ago

Jazz Pharmaceuticals plc (JAZZ): Among The Stocks With Biggest Upside Potential According to Hedge Funds

JAZZ

Argus Research

a month ago

JAZZ: Lowering target price to $118.00

Jazz Pharmaceuticals Plc (JAZZ): Among Seth Klarman’s Top Stock Picks
JAZZ

Insider Monkey

a month ago

Jazz Pharmaceuticals Plc (JAZZ): Among Seth Klarman’s Top Stock Picks

Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market
JAZZ

GuruFocus.com

a month ago

Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market

JAZZ

MT Newswires

a month ago

RBC Lifts Price Target on Jazz Pharmaceuticals to $175 From $174, Keeps Outperform Rating

Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now?
JAZZ

Insider Monkey

a month ago

Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now?

Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
JAZZ

Zacks

a month ago

Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock

Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now?
JAZZ

Zacks

a month ago

Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now?

Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss
JAZZ

Simply Wall St.

2 months ago

Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss

JAZZ

MT Newswires

2 months ago

Jazz Pharmaceuticals Says Gastric Cancer Therapy Shows Promise in Mid-Stage Study

Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024

Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024

Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock?
JAZZ

Insider Monkey

2 months ago

Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock?

Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024

Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now
JAZZ

Insider Monkey

2 months ago

Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now

JAZZ

MT Newswires

2 months ago

Jazz Pharmaceuticals Prices $850 Million Senior Notes Offering

Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases

JAZZ

MT Newswires

2 months ago

Jazz Pharmaceuticals Launches $850 Million Senior Notes Offering, $150 Million Share Buyback

Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases
JAZZ

PR Newswire

2 months ago

Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases

Why Is Jazz (JAZZ) Up 1.1% Since Last Earnings Report?
JAZZ

Zacks

3 months ago

Why Is Jazz (JAZZ) Up 1.1% Since Last Earnings Report?

Jazz Pharmaceuticals plc (JAZZ): Top ADR Stock According to Hedge Funds
JAZZ

Insider Monkey

3 months ago

Jazz Pharmaceuticals plc (JAZZ): Top ADR Stock According to Hedge Funds

JAZZ

MT Newswires

3 months ago

Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug

JAZZ

Argus Research

3 months ago

JAZZ: What does Argus have to say about JAZZ?

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
JAZZ

Pharmaceutical Technology

3 months ago

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
JAZZ

Clinical Trials Arena

3 months ago

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial

JAZZ

MT Newswires

3 months ago

Jazz Pharmaceuticals Epilepsies Drug Study Misses Primary Efficacy Goal

Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies
JAZZ

PR Newswire

3 months ago

Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
JAZZ

PR Newswire

3 months ago

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences

JAZZ

Argus Research

3 months ago

JAZZ: Raising target price to $121.00

Axsome (AXSM) Banks on Auvelity & Sunosi to Fuel Growth
JAZZ

Zacks

3 months ago

Axsome (AXSM) Banks on Auvelity & Sunosi to Fuel Growth

AMNEAL PHARMACEUTICALS, INC. (AMRX) Soars to 52-Week High, Time to Cash Out?
JAZZ

Zacks

3 months ago

AMNEAL PHARMACEUTICALS, INC. (AMRX) Soars to 52-Week High, Time to Cash Out?

Shareholders Will Be Pleased With The Quality of Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings
JAZZ

Simply Wall St.

3 months ago

Shareholders Will Be Pleased With The Quality of Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings

JAZZ or CTLT: Which Is the Better Value Stock Right Now?
JAZZ

Zacks

3 months ago

JAZZ or CTLT: Which Is the Better Value Stock Right Now?

Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade
JAZZ

Zacks

3 months ago

Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade

Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now?
JAZZ

Zacks

3 months ago

Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now?

Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue Trends
JAZZ

Zacks

3 months ago

Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue Trends

Jazz Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
JAZZ

Simply Wall St.

3 months ago

Jazz Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations

JAZZ

MT Newswires

3 months ago

RBC Trims Price Target on Jazz Pharmaceuticals to $174 From $175, Keeps Outperform Rating

JAZZ

Morningstar Research

3 months ago

Analyst Report: Jazz Pharmaceuticals plc

JAZZ

MT Newswires

3 months ago

Jazz Pharmaceuticals Q2 Non-GAAP Earnings, Revenue Rise, 2024 Outlook Updated

Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates
JAZZ

Zacks

3 months ago

Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates

JAZZ

Associated Press Finance

3 months ago

Jazz: Q2 Earnings Snapshot

Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance
JAZZ

PR Newswire

3 months ago

Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance

Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting

Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
JAZZ

Zacks

4 months ago

Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
JAZZ

Zacks

4 months ago

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

JAZZ

Argus Research

4 months ago

JAZZ: Raising target price to $114.00

Nanotechnology in medicine: Who are the leading public companies?
JAZZ

Medical Device Network

4 months ago

Nanotechnology in medicine: Who are the leading public companies?

JAZZ

MT Newswires

4 months ago

Jazz Pharmaceuticals Reprices $2.7 Billion Outstanding Balance of Term Loan Facility

Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026

Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024

JAZZ

Argus Research

4 months ago

JAZZ: Raising target price to $111.00

Aurinia (AUPH) Soars 6.6%: Is Further Upside Left in the Stock?
JAZZ

Zacks

4 months ago

Aurinia (AUPH) Soars 6.6%: Is Further Upside Left in the Stock?

JAZZ

Argus Research

4 months ago

JAZZ: Lowering target price to $106.00

JAZZ

MT Newswires

4 months ago

RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating

Share on Social Networks: